|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Costs and expenses: | |||||
| Cost of revenue (exclusive of depreciation and amortization shown separately below) | |||||
| Selling and marketing expense | |||||
| General and administrative expense | |||||
| Product development | |||||
| Depreciation | |||||
| Amortization of intangibles | |||||
| Change in fair value of contingent consideration | |||||
| Restructuring and severance | |||||
| Litigation settlements and contingencies | |||||
| Total costs and expenses | |||||
| Operating income (loss) | |||||
| Other (expense) income, net: | |||||
| Interest (expense) income, net | |||||
| Other income (expense) | |||||
| Income (loss) before income taxes | |||||
| Income tax benefit (expense) | |||||
| Net (loss) income from continuing operations | |||||
| Loss from discontinued operations, net of tax | |||||
| Net income (loss) | |||||
| Comprehensive income (loss) | |||||
| Weighted average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Net income (loss) per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
Loading...